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Introduction 
Interest towards Early Repolarization (ER) rose after the theoretical proposal
1
 
and the clinical demonstration
2
 that certain electrocardiographic patterns 
characterized by an elevation of the J point were associated with an increased 
risk of sudden cardiac death in otherwise healthy individuals. Previous studies 
showed that only the rare pattern characterized by a significant J point 
elevation (≥ 2 mm) in the inferior leads associated with a slurred J wave and a 
horizontal/descending ST segment was associated with an increased risk of 
death (whether arrhythmic, from cardiac or any cause).
3-6
  Whether this 
pattern may constitute a real primary arrhythmic disorder rather than a 
predisposing substrate facilitating arrhythmias during ischemic episodes is still 
a matter of debate. 
Moreover, those findings are somehow in contrast with the clinical evidence of 
patients presenting  with idiopathic ventricular fibrillation and several different 
morphologies of the J wave and ST segment, questioning what is the real ECG 
marker able to distinguish between a malignant and a benign form of ER.  
Thus, the aim of the present study is to compare the amplitude of J waves by 
measuring  slope and  duration in ER syndrome patients and healthy athletes 
with ECG evidence of J point elevation associated with J wave and to evaluate 
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its potential role as an electrocardiographic marker of increased arrhythmic 
risk. 
Methods 
Cases 
A systematic review was performed to select those manuscripts reporting good 
quality, undistorted, preferably 12 leads ECG tracings of patients with episodes 
of idiopathic ventricular fibrillation and ECG evidence of J point elevation 
associated with J wave commonly accepted and referenced in contemporary 
works as patients with ER syndrome. 
Only manuscripts reporting data and ECG of patients with isolated ER 
syndrome, not associated with any other form of congenital (Brugada 
syndrome, SQTS, LQTS, structural heart disease) or acquired causes of J point 
elevation (ER in the setting of acute myocardial ischemia) were taken into 
account. 
Ovid MEDLINE, PubMed, CENTRAL, and Excepta Medica (EMBASE) were 
searched up to February 2014 for suitable works, bibliographies of pertinent 
articles were also reviewed to search for relevant publications.  
Detailed references of the selected manuscripts and tracings are reported in 
table 1. For all cases, the index clinical event was obtained through the 
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manuscript while J wave’s  morphology, localization, entity of J point elevation,  
were derived from available data (description and/or ECG) while duration and 
slope of the J wave were electronically measured from the published ECG 
tracings with an electronic caliper by two independent cardiologists. For both 
athletes and cases the (available) lead showing the wider J wave was chosen 
for measurements. 
Controls 
Controls were selected from our database comprising clinical, 
electrocardiographic, echocardiographic and long term follow up data of 338 
male professional elite athletes, members of soccer clubs participating in the 
Italian national football championships, who were screened for a first pre-
participation evaluation between June 1980 and April 2008 at the Turin 
Institute of Sport Medicine. A detailed description of this population was 
previously published.
27
  
Briefly, the incidence of J point elevation in this population was 35.6% and at a 
median follow up of 13.3 years no episodes of sudden cardiac death were 
observed. 
From this initial population only subjects with a significant J point elevation 
(≥0.2mV) and evidence of J wave either with a notched or a slurred 
appearance, whatever the morphology of the ST segment 
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(horizontal/descending or ascending), were selected. A J point elevation 
≥0.2mV was selected as an inclusion criteria in both cases and controls in order 
to obtain reliable measurements of the slope and duration of the J wave. 
Subjects with the traditional form of early repolarization characterized by J 
point elevation and upward displacement of the ST segment but without 
evidence of J wave were excluded. 
ECG analysis. 
All electrocardiograms were digitally acquired and analyzed by two 
independent reviewers who were blinded to all subjects characteristics. In 
ambiguous cases final adjudication was achieved by consensus with a third 
reviewer. 
All measurements were performed using a digital caliper and protractor at a 
400% magnification. 
Measurements were performed following the recent recommendations on J 
point identification and measurement provided by the consensus paper 
published in July 2015 by Macfarlane et al. in the Journal of the American 
College of Cardiology
28
. 
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In both cases and controls the duration of the J wave was measured as the 
interval comprised between the J point (J onset or Jo) and the intersection of 
the tangent to the J wave with the isoelectric line or the change of slope of the 
J wave into the ST/T wave, whatever come first. To assess the slope of the J 
wave, the “J angle” (the angle between an ideal line drawn from the J point (Jo 
point)  perpendicular to the isoelectric line and the tangent to the J wave) was 
digitally measured. Angle measurements are expressed in sexagesimal degrees 
(°). A graphic description of how measurements were preformed is provided in 
figure 1. 
According to previously proposed morphological classifications of J waves, a 
notched J wave was defined by the presence of a sharp and well-defined hump 
immediately after the R-wave, while a slurred J wave was identified when the 
QRS-ST transition was characterized  by a change in the slope of the terminal 
portion of the R wave.
3,4
  To estimate the entity of J point elevation  the height 
of the Jo point was measured, with the isolectric line considered as a baseline.  
Statistical analysis 
Descriptive analysis was performed using mean±standard deviation for 
continuous variables and counts and percentages for categorical variables. 
Comparisons between groups were performed with the Student’s t-Test, one 
way ANOVA and Yates corrected or uncorrected Chi-squared method when 
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appropriate. All probability values were considered to be significant at a value ≤ 
0.05. All the analyses were performed with SPSS software (SPSS, Chicago, IL).  
Results 
Out of 1523 papers evaluated only 21 works reported original, non-distorted, 
interpretable ECG tracings of 27 different patients with idiopathic ventricular 
fibrillation due to early repolarization syndrome. 
Table 1 reports the clinical and ECG data obtained from original reports. 
Out of 338 healthy, professional top series football players only 24 showed a J 
point elevation ≥0.2 mV (and a clearly identifiable J waves with a notched or 
slurred appearance). Table 2 reports the clinical characteristics of controls. 
J point elevation was 0.307±0.125 mV in cases and 0.269±0.103 mV in controls 
(p=0.243) with a wide overlap of measurements between the two populations 
(Fig 2, left panel).  
Cases showed a significantly longer duration of the J waves if compared to 
controls (69.48±27.93 vs 35.05±10.33 ms; p<0.001). None of the controls 
showed a duration greater than 60 ms while 15 out of 27 cases (55.5%) showed 
a J wave duration longer than 60 ms (Fig 2, central panel). 
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When compared to controls, cases showed a significantly wider J angle 
(32.59±10.4° vs 20.00±6.84°; p<0.001), with only 2 out of 24 controls (8.3%) 
showing a J angle >30°(Fig 2, right panel). 
Figure 3 shows the plot of J wave duration as expressed in millimeters 
(horizontal axis) and J angle (vertical axis). As shown in the graph controls, 
characterized by a short and steep J waves, are clusterized in the left inferior 
corner. None of the healthy athletes showed a duration longer than 60 ms in 
combination with an angle greater than 30°. On the other hand, cases showed 
a wide dispersion of measurements. Few of them had a short and steep J wave, 
while the majority showed, alone or in combination, a long and delayed J wave. 
Discussion 
The main finding of this work is that patients reported in contemporary 
literature with episodes of idiopathic ventricular fibrillation deemed to be 
related to ER syndrome show a slow and delayed J wave if compared to healthy 
controls, representing  a new potential tool to discriminate between benign 
and malignant early repolarization. 
Despite the recent rise of interest, clear electrocardiographic criteria to stratify 
the arrhythmic risk of subjects with ER are still missing. Several previous 
retrospective,  population based works identified the rare pattern 
characterized by significant J point elevation (≥0.2 mV) in the inferior leads 
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concomitant with a J wave and a horizontal/descending ST segment as 
associated with an increased risk of (late) death, from cardiac or any cause. 
Subjects  with a slurred J wave showed an increased risk if compared to those 
with a notched J wave.
5
 Those works failed to solve the issue whether deaths 
were effectively related to primary arrhythmic episodes, fatal arrhythmias in 
the setting of ischemic events or other causes.  
As for the Brugada syndrome,the electrophysiological mechanism deemed to 
be responsible for the arrhythmogenicity of ER is a Ito-mediated loss of the 
epicardial action potential dome causing transmural dispersion of 
repolarization, a trigger for phase 2 reentry mediated short coupled ventricular 
extra beats, a potential cause of ventricular arrhythmias.
29,30
 Thus the basic 
idea supporting our work is that J wave’s amplitude by impacting on the 
persistence of the J wave (i.e.  longer duration and wider angle) will prolong the 
transmembrane dispersion of repolarization, thus enhancing the 
arrhythmogenic potential. 
Similarly, subjects with Brugada type II or III ecg patterns with a drug elicited 
type I pattern showed a delayed and slurred J wave, evident with an ample 
angle between the upslope of the S wave and the downslope of the r’wave  as 
compared to subjects with a negative drug challenge, supporting the 
hypothesis that the amplitude of the J wave may be an effective 
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electrocardiographic marker of increased arrhythmic risk.
 31 
To the best of our 
knowledge, this is the first paper to systematically describe J wave’s duration 
and slope in patients with ER syndrome and controls with ECG evidence of ER, a 
characteristic that has been advocated,  but not yet evaluated, as a potential 
marker of increased risk.
30
 
Our data are hypothesis generating: the amplitude of the J wave, regardless of 
the morphology (slurred/notched) or location (inferior/lateral/combined) could 
represent an electrocardiographic marker able to distinguish between a benign 
and a malignant form of ER. 
Lessons learned from other primary electrical disorders such as Brugada 
syndrome and LQTS or other ion channel diseases taught that beside the 
presence of an electrocardiographic pattern, its extent and persistence may 
constitute a useful prognostic marker, further supporting our hypothesis. 
Moreover prominent J waves are known to anticipate arrhythmic episodes in 
patients with ER syndrome
2
, another evidence supporting our hypothesis.  
In line with previous works, J point elevation as itself doesn’t seem to play a 
real role as a ECG marker of increased arrhythmic risk, being slightly, but not 
significantly increased in cases versus controls.
2-6
 
As evident figure 3, while controls are grouped in the right inferior corner of 
the plot, ER cases showed a true disorder of the early repolarization process, 
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evident as a wide dispersion of measurements. None of the controls showed a 
duration longer than 60 ms while a minority showed a slope greater than 30°. 
Only cases showed J waves >60 ms and a slope exceeding 30°, this representing 
a potential discriminant between a malignant and a benign form of ER that will 
be prospectively evaluated in a large population study planned to start in the 
next future. 
Several limitations should be mentioned. First, the hypothesis was only derived 
but not yet validated in an independent large volume population.  Second, the 
target of this work was not to definitely solve the ultimate question on how to 
stratify the risk of subjects with early repolarization, but rather to rise the 
interest toward a poorly investigated aspect such as the morphology of the J 
wave. Third, cases were evaluated only on ECG obtained from literature. Even if 
only high quality, non distorted, clearly interpretable tracing  were selected, 
the editorial process could have introduced some minor distortions that could 
eventually impact on the results. Moreover, none of the evaluated works 
reported an accurate description of the filters used when recording the ECGs, 
this limitation mostly attributable to a lack of methodological accuracy of the 
original works. Finally, ER has both in the benign and malignant form a waxing 
and waning appearance, that is known to alter its electrocardiographic 
characteristics, and thus the evaluated parameters. Nevertheless, prominent J 
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waves are known forerunners of incumbent arrhythmic events, thus ultimately 
supporting our hypothesis. 
In conclusion, this is the first paper to report the potential role of J wave’s 
duration and slope as ECG markers of an increased arrhythmic risk. A delayed 
and prolonged J wave, marker of a transmural dispersion of repolarization may 
represent the new discriminant able to distinguish between benign and 
malignant ER. A prospective validation of this hypothesis is needed. 
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Table legends 
Table 1. References, clinical and electrocardiographic characteristics of cases. 
Table 2. Clinical and electrocardiographic characteristics of control athletes. 
 
Figure legends 
Figure 1.  Measurement of slope and duration of the J wave. Panel A: notched 
J wave in a control subject; B:  slurred J wave in a control subject; C notched J 
wave in a case; D: slurred J wave in a case. 
Figure 2. Plot of J point elevation, duration and slope of the J wave in control 
subjects and cases. 
Figure 3. Scatter plot of J wave duration (mm, horizontal axis) and slope 
(degrees, vertical axis). 
Fig 1.
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Fig 2. 
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Fig 3. 
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Table 1. References, clinical and electrocardiographic characteristics of cases.  
Subj
ect 
num
ber 
Publication Patient 
characteris
J wave characteristics H
R Author Ye
ar 
Journal Age 
(yea
rs) 
Eve
nt 
Morpho
logy 
Localiza
tion 
J 
point 
elevat
ion 
(mm) 
Durat
ion 
(ms) 
Slo
pe 
(°) 
Lead of 
measure
ment 
 
1 Haissagu
2
20 N Eng J  IVF S n.a. 3 72 33 n.a.  
2 Derval
7
 20 JACC  IVF NS Inf-Lat 3 58 30 II 4
3 Derval
7
 20
11 
JACC 29 IVF S n.a. 2,5 53 35 n.a.  
4 Merchan
8
20 Am J  IVF N Lat 2 50 33 V4  
5 Merchan
8
20 Am J  IVF S Inf-Lat 2 70 45 aVF  
6 Nam
9
 20 Circ J 53 IVF N Lat 3 35 34 V5  
7 Nam
9
 20 Circ J 50 IVF N Lat 5 70 45 aVL 7
8 Riera
10
 20 J 29 IVF S Inf-Lat 6 126 30 aVF  
9 Rosso
3
 20
08 
JACC  IVF S Inf 2 67 37 III 8
2 10 Rosso
3
 20 JACC  IVF S Inf 2 60 32 aVF 7
11 Watanab
11
20 Int J 29 IVF S Inf 2 45 40 II 5
12 Amara
12
 20
12 
Ann 
Cardiol 
61 IVF S Inf-Lat 2,5 59 48 V4 6
2 13 Sacher
13
 20 J 
Electroca
14 IVF NS All 4 167 45 II  
14 Ohukbo
1
4
20 J Cardiol 41 IVF N Inf  59 31 II  
15 Ohukbo
1
4
 
20
12 
J Cardiol 27 IVF N Lat  73 33 V6  
16 Nakagaw
15
20 Heart 42 IVF NS Inf-Lat 5 84 15 V5  
17 Aizawa
16
 20 JACC 34 IVF N Lat 4,5 87 14 V6  
18 Garg
17
 19 J 
Cardiova
18 IVF/ N Lat 4 56 10 V5 4
19 Bastiane
18
20 Heart 38 IVF N Inf 3 83 29 III 8
20 Katsuum
19
20 Int J  IVF S Inf-Lat 1,5 30 30 V6  
21 Watanab
e
20
 
20
11 
Circ 
Arrhyth
36 IVF S Inf 3 91 41 aVF  
22 Nam
21 
20 Eu  31 IVF NS Lat 5 71 23 V4 5
23 Hu
22
 20 Int J 20 IVF N All 6 48 19 V6  
24 Talib
23
 20
13 
J 
Cardiova
57 IVF NS Inf-Lat 4 60 36 aVF  
25 Shinoara
24
20 Heart 37 IVF N* n.a. 3 60 22 n.a. 5
26 Takagi
25
 20 J 27 IVF S Inf 3 59 42 aVF  
27 Takagi
25
 20 J 
Cardiova
29 IVF S Inf 3 84 48 aVF  
IVF = idiopatic ventricular fibrillation; SD = sudden death; HR = heart rate (bpm); N = notched; S = slurred; Inf = 
inferior; Lat = lateral; Inf-Lat = inferolateral; n.a. = not available *on showed lead; 
§
Circ Arrhythm Electrophysiol; 
#
J Cardiovasc Electrophysiol. 
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Table 2. Clinical and electrocardiographic characteristics of control athletes. 
Subject 
number 
Age 
(years) 
J wave characteristics HR 
Morphology Localization J point 
elevation (mm) 
Duration 
(ms) 
Slope 
(°) 
Lead of 
measurement 
1 30 N Inf-Lat 2 33 18 II 51 
2 24 N Lat 4 41 17 II 62 
3 18 S Inf 3 34 12 aVF 50 
4 23 N Lat 2 34 21 III 40 
5 25 S Inf 3 37 20 III 41 
6 28 N Inf-Lat 2 51 32 V5 38 
7 29 N Lat 3 17 13 V4 46 
8 23 N+S Inf-Lat 4 37 21 V5 54 
9 25 N+S Inf-Lat 4 34 13 V5 44 
10 16 N Lat 3 17 18 V4 75 
11 28 N+S Inf-Lat 2 27 23 V4 52 
12 25 N Lat 3 31 30 II 75 
13 33 N+S Inf-Lat 2 47 28 II 44 
14 26 N+S Inf-Lat 4 47 20 V5 47 
15 30 N+S Inf-Lat 2 37 33 II 58 
16 22 N+S Inf-Lat 2 27 15 V6 53 
17 37 N Lat 2 24 19 V5 57 
18 22 N Lat 2 31 29 V4 63 
19 28 N+S Inf-Lat 3 17 13 V4 66 
20 17 N+S Inf 3 53 22 III 54 
21 14 N Inf 3 47 14 III 72 
22 20 N Lat 6 44 9 III 55 
23 14 N Inf 2 38 12 III 62 
24 29 N Lat 4 37 14 V4 50 
HR = heart rate (bpm); N = notched; S = slurred; Inf = inferior; Lat = lateral; Inf-Lat = inferolateral 
 
 
